Kazia Therapeutics Stock (NASDAQ: KZIA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 377.000 / 808.131K |
Day Range | - - - |
52 Wk Range | 0.187 - 1.680 |
Market Cap | $8.270M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kazia Therapeutics (NASDAQ: KZIA) through any online brokerage.
Other companies in Kazia Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP), BioRestorative Therapies (NASDAQ:BRTX), NexImmune (NASDAQ:NEXI) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Kazia Therapeutics (NASDAQ: KZIA) was reported by HC Wainwright & Co. on Tuesday, April 11, 2023. The analyst firm set a price target for 2.00 expecting KZIA to rise to within 12 months (a possible 537.55% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $0.3137 last updated Today at March 28, 2024 at 4:35 AM EDT.
There are no upcoming dividends for Kazia Therapeutics.
Kazia Therapeutics’s H1 earnings are confirmed for Tuesday, April 9, 2024.
There is no upcoming split for Kazia Therapeutics.
Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.